NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

癲癇發作治療市場:全球產業分析,規模,佔有率,成長,趨勢,及預測(2020年∼2030年)

Epileptic Seizures Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

出版商 Transparency Market Research 商品編碼 974870
出版日期 內容資訊 英文 219 Pages
商品交期: 最快1-2個工作天內
價格
癲癇發作治療市場:全球產業分析,規模,佔有率,成長,趨勢,及預測(2020年∼2030年) Epileptic Seizures Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030
出版日期: 2020年10月30日內容資訊: 英文 219 Pages
簡介

本報告提供癲癇發作治療市場相關調查,市場概要,以及各治療藥物,各類型,各給藥途徑,各流通管道,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

第2章 假設與調查手法

第3章 摘要整理:全球癲癇發作治療市場

第4章 市場概要

  • 簡介
    • 市場定義
    • 產業的演進/發展
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 全球癲癇發作治療市場分析與預測,2018年∼2030年
    • 市場收益預測(百萬美元)

第5章 重要的洞察

  • 開發平台分析
  • 在主要國家的全球性疾病得病率和發生率
  • 主要的產業活動(合併,收購,聯合,聯盟等)
  • COVID-19大流行對產業的影響(價值鏈及短期/中期/長期的影響)

第6章 全球癲癇發作治療市場分析與預測,各治療藥物

  • 簡介和定義
  • 主要調查結果/開發
  • 市場價值預測,各治療藥物,2018∼2030年
    • Midazolam
    • Alprazolam
    • Diazepam
    • Lorazepam
    • Phenytoin
    • Fosphenytoin
    • 其他
  • 各治療學市場魅力分析

第7章 全球癲癇發作治療市場分析與預測,各類型

  • 簡介和定義
  • 主要調查結果/開發
  • 各類型的市場價值預測,2018∼2030年
    • 反復發作
    • 癲癇重積狀態
    • 其他
  • 各類型的市場魅力分析

第8章 全球癲癇發作治療市場分析與預測,各給藥途徑

  • 簡介和定義
  • 主要調查結果/開發
  • 市場價值預測,各給藥途徑,2018∼2030年
    • 口服/臉頰方面
    • 經腸
    • 經鼻子
    • 非口服
  • 各給藥途徑的市場魅力分析

第9章 全球癲癇發作治療市場分析與預測,各流通管道

  • 簡介和定義
  • 主要調查結果/開發
  • 各流通管道的市場價值預測,2018∼ 2030年
    • 院內藥局
    • 零售藥局
    • 線上藥局
  • 各流通管道的市場魅力分析

第10章 全球癲癇發作治療市場分析與預測,各地區

  • 主要調查結果
  • 各地區的市場價值預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 各國家/地區的市場魅力分析

第11章 北美癲癇發作治療市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場價值預測,各治療藥物,2018∼2030年
    • Midazolam
    • Alprazolam
    • Diazepam
    • Lorazepam
    • Phenytoin
    • Fosphenytoin
    • 其他
  • 市場價值預測,各類型,2018∼2030年
    • 反復發作
    • 癲癇重積狀態
    • 其他
  • 市場價值預測,各給藥途徑,2018∼2030年
    • 口服/臉頰方面
    • 直腸
    • 鼻子
    • 非口服
  • 市場價值預測,各流通管道,2018∼2030年
    • 院內藥局
    • 零售藥局
    • 線上藥局
  • 市場價值預測,各國,2018∼2030年
    • 美國
    • 加拿大
  • 市場魅力分析
    • 各治療學
    • 各類型
    • 各給藥途徑
    • 各流通管道
    • 各國

第12章 歐洲癲癇發作治療市場分析與預測

第13章 亞太地區的癲癇發作治療市場分析與預測

第14章 南美癲癇發作治療市場分析與預測

第15章 中東及非洲癲癇發作治療市場分析與預測

第16章 競爭情形

  • 市場參與者-競爭矩陣(企業的層和各規模)
  • 市場佔有率/位置分析,各企業,2019年
  • 商務競爭策略
  • 企業簡介

16.4.1. Bausch Health Companies, Inc.

16.4.2. GlaxoSmithKline plc.

16.4.3. UCB SA

    • Pfizer, Inc.

16.4.5. Apotex, Inc.

16.4.6. Alexza Pharmaceuticals, Inc.

    • Veriton Pharma

16.4.8. Veriton Pharma

目錄
Product Code: TMRGL79717

Title:
Epileptic Seizures Treatment Market (Therapeutic: Midazolam, Alprazolam, Diazepam, Lorazepam, Phenytoin, Fosphenytoin, and Others; Type: Repetitive Seizures, Status Epilepticus, and Others; Route of Administration: Oral/Buccal, Rectal, Nasal, and Parenteral; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030.

Epileptic Seizures Treatment Market - Scope of the Report

TMR's report on the global epileptic seizures treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the overall market revenue of the global epileptic seizures treatment market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global epileptic seizures treatment market for the forecast period.

The report has been prepared after extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global epileptic seizures treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomena in the global epileptic seizures treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global epileptic seizures treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global epileptic seizures treatment market.

The report delves into the competition landscape of the global epileptic seizures treatment market. Key players operating in the global epileptic seizures treatment market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global epileptic seizures treatment market that have been profiled in this report.

Key Questions Answered in Epileptic Seizures Treatment Market Report

What is the sales/revenue generated by each therapeutic, type, route of administration, and distribution channel segment of the global epileptic seizures treatment market across all regions during the forecast period?

What are the opportunities in the global epileptic seizures treatment market?

What are the major drivers, restraints, opportunities, and threats in the market?

Which region is likely to expand at the fastest CAGR during the forecast period?

Which epileptic seizures treatment segments are expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?

What is the market share or position of different companies operating in the global market in 2019?

Epileptic Seizures Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global epileptic seizures treatment market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, pipeline analysis, disease prevalence in key countries, key industry events, and impact of COVID-19 in global epileptic seizures treatment market have been provided.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small ones. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global epileptic seizures treatment market in terms of therapeutic, type, route of administration, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global epileptic seizures treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Epileptic Seizures Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Market Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Epileptic Seizures Treatment Market Analysis and Forecast, 2018-2030
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Disease Prevalence & Incidence Rate globally with key countries
  • 5.3. Key Industry Events (mergers, acquisitions, collaborations, partnerships, etc.)
  • 5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

6. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Therapeutics

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Therapeutics, 2018-2030
    • 6.3.1. Midazolam
    • 6.3.2. Alprazolam
    • 6.3.3. Diazepam
    • 6.3.4. Lorazepam
    • 6.3.5. Phenytoin
    • 6.3.6. Fosphenytoin
    • 6.3.7. Others
  • 6.4. Market Attractiveness Analysis, by Therapeutics

7. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Type, 2018-2030
    • 7.3.1. Repetitive Seizures
    • 7.3.2. Status Epilepticus
      • 7.3.2.1. Convulsive Status Epilepticus
      • 7.3.2.2. Non-convulsive Status Epilepticus
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Type

8. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2018-2030
    • 8.3.1. Oral/Buccal
    • 8.3.2. Rectal
    • 8.3.3. Nasal
    • 8.3.4. Parenteral
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Distribution Channel, 2018-2030
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Country/Region

11. North America Epileptic Seizures Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Therapeutics, 2018-2030
    • 11.2.1. Midazolam
    • 11.2.2. Alprazolam
    • 11.2.3. Diazepam
    • 11.2.4. Lorazepam
    • 11.2.5. Phenytoin
    • 11.2.6. Fosphenytoin
    • 11.2.7. Others
  • 11.3. Market Value Forecast, by Type, 2018-2030
    • 11.3.1. Repetitive Seizures
    • 11.3.2. Status Epilepticus
      • 11.3.2.1. Convulsive Status Epilepticus
      • 11.3.2.2. Non-convulsive Status Epilepticus
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Route of Administration, 2018-2030
    • 11.4.1. Oral/Buccal
    • 11.4.2. Rectal
    • 11.4.3. Nasal
    • 11.4.4. Parenteral
  • 11.5. Market Value Forecast, by Distribution Channel, 2018-2030
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. Market Value Forecast, by Country, 2018-2030
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Therapeutics
    • 11.7.2. By Type
    • 11.7.3. By Route of Administration
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Epileptic Seizures Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Therapeutics, 2018-2030
    • 12.2.1. Midazolam
    • 12.2.2. Alprazolam
    • 12.2.3. Diazepam
    • 12.2.4. Lorazepam
    • 12.2.5. Phenytoin
    • 12.2.6. Fosphenytoin
    • 12.2.7. Others
  • 12.3. Market Value Forecast, by Type, 2018-2030
    • 12.3.1. Repetitive Seizures
    • 12.3.2. Status Epilepticus
      • 12.3.2.1. Convulsive Status Epilepticus
      • 12.3.2.2. Non-convulsive Status Epilepticus
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Route of Administration, 2018-2030
    • 12.4.1. Oral/Buccal
    • 12.4.2. Rectal
    • 12.4.3. Nasal
    • 12.4.4. Parenteral
  • 12.5. Market Value Forecast, by Distribution Channel, 2018-2030
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Market Value Forecast, by Country/Sub-region, 2018-2030
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Therapeutics
    • 12.7.2. By Type
    • 12.7.3. By Route of Administration
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Epileptic Seizures Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Therapeutics, 2018-2030
    • 13.2.1. Midazolam
    • 13.2.2. Alprazolam
    • 13.2.3. Diazepam
    • 13.2.4. Lorazepam
    • 13.2.5. Phenytoin
    • 13.2.6. Fosphenytoin
    • 13.2.7. Others
  • 13.3. Market Value Forecast, by Type, 2018-2030
    • 13.3.1. Repetitive Seizures
    • 13.3.2. Status Epilepticus
      • 13.3.2.1. Convulsive Status Epilepticus
      • 13.3.2.2. Non-convulsive Status Epilepticus
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Route of Administration, 2018-2030
    • 13.4.1. Oral/Buccal
    • 13.4.2. Rectal
    • 13.4.3. Nasal
    • 13.4.4. Parenteral
  • 13.5. Market Value Forecast, by Distribution Channel, 2018-2030
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Market Value Forecast, by Country/Sub-region, 2018-2030
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Therapeutics
    • 13.7.2. By Type
    • 13.7.3. By Route of Administration
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country/Sub-region

14. Latin America Epileptic Seizures Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Therapeutics, 2018-2030
    • 14.2.1. Midazolam
    • 14.2.2. Alprazolam
    • 14.2.3. Diazepam
    • 14.2.4. Lorazepam
    • 14.2.5. Phenytoin
    • 14.2.6. Fosphenytoin
    • 14.2.7. Others
  • 14.3. Market Value Forecast, by Type, 2018-2030
    • 14.3.1. Repetitive Seizures
    • 14.3.2. Status Epilepticus
      • 14.3.2.1. Convulsive Status Epilepticus
      • 14.3.2.2. Non-convulsive Status Epilepticus
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by Route of Administration, 2018-2030
    • 14.4.1. Oral/Buccal
    • 14.4.2. Rectal
    • 14.4.3. Nasal
    • 14.4.4. Parenteral
  • 14.5. Market Value Forecast, by Distribution Channel, 2018-2030
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Market Value Forecast, by Country/Sub-region, 2018-2030
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Therapeutics
    • 14.7.2. By Type
    • 14.7.3. By Route of Administration
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Epileptic Seizures Treatment Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Therapeutics, 2018-2030
    • 15.2.1. Midazolam
    • 15.2.2. Alprazolam
    • 15.2.3. Diazepam
    • 15.2.4. Lorazepam
    • 15.2.5. Phenytoin
    • 15.2.6. Fosphenytoin
    • 15.2.7. Others
  • 15.3. Market Value Forecast, by Type, 2018-2030
    • 15.3.1. Repetitive Seizures
    • 15.3.2. Status Epilepticus
      • 15.3.2.1. Convulsive Status Epilepticus
      • 15.3.2.2. Non-convulsive Status Epilepticus
    • 15.3.3. Others
  • 15.4. Market Value Forecast, by Route of Administration, 2018-2030
    • 15.4.1. Oral/Buccal
    • 15.4.2. Rectal
    • 15.4.3. Nasal
    • 15.4.4. Parenteral
  • 15.5. Market Value Forecast, by Distribution Channel, 2018-2030
    • 15.5.1. Hospital Pharmacies
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Pharmacies
  • 15.6. Market Value Forecast, by Country/Sub-region, 2018-2030
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Therapeutics
    • 15.7.2. By Type
    • 15.7.3. By Route of Administration
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share/Position Analysis, by Company, 2019
  • 16.3. Competitive Business Strategies
  • 16.4. Company Profiles
    • 16.4.1. Bausch Health Companies, Inc.
      • 16.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.4.1.2. Company Financials
      • 16.4.1.3. Growth Strategies
      • 16.4.1.4. SWOT Analysis
    • 16.4.2. GlaxoSmithKline plc.
      • 16.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.4.2.2. Company Financials
      • 16.4.2.3. Growth Strategies
      • 16.4.2.4. SWOT Analysis
    • 16.4.3. UCB S.A.
      • 16.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.4.3.2. Company Financials
      • 16.4.3.3. Growth Strategies
      • 16.4.3.4. SWOT Analysis
    • 16.4.4. Pfizer, Inc.
      • 16.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.4.4.2. Company Financials
      • 16.4.4.3. Growth Strategies
      • 16.4.4.4. SWOT Analysis
    • 16.4.5. Apotex, Inc.
      • 16.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.4.5.2. Company Financials
      • 16.4.5.3. Growth Strategies
      • 16.4.5.4. SWOT Analysis
    • 16.4.6. Alexza Pharmaceuticals, Inc.
      • 16.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.4.6.2. Company Financials
      • 16.4.6.3. Growth Strategies
      • 16.4.6.4. SWOT Analysis
    • 16.4.7. Neurelis, Inc.
      • 16.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.4.7.2. Company Financials
      • 16.4.7.3. Growth Strategies
      • 16.4.7.4. SWOT Analysis
    • 16.4.8. Veriton Pharma
      • 16.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.4.8.2. Company Financials
      • 16.4.8.3. Growth Strategies
      • 16.4.8.4. SWOT Analysis

List of Tables

  • Table 01: Pipeline Analysis
  • Table 02: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018-2030
  • Table 03: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018-2030
  • Table 04: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018-2030
  • Table 05: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 06: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 07: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 08: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 09: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018-2030
  • Table 10: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018-2030
  • Table 11: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018-2030
  • Table 12: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 13: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 14: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 15: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018-2030
  • Table 16: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018-2030
  • Table 17: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018-2030
  • Table 18: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 19: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 20: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 21: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018-2030
  • Table 22: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018-2030
  • Table 23: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018-2030
  • Table 24: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 25: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 26: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 27: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018-2030
  • Table 28: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018-2030
  • Table 29: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018-2030
  • Table 30: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 31: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 32: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 33: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018-2030
  • Table 34: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018-2030
  • Table 35: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018-2030
  • Table 36: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 37: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030

List of Figures

  • Figure 01: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 02: Global Epileptic Seizures Treatment Market Value Share, by Therapeutics, 2019
  • Figure 03: Global Epileptic Seizures Treatment Market Value Share, by Type, 2019
  • Figure 04: Global Epileptic Seizures Treatment Market Value Share, by Route of Administration 2019
  • Figure 05: Global Epileptic Seizures Treatment Market Value Share, by Distribution Channel, 2019
  • Figure 06: Global Epileptic Seizures Treatment Market Value Share, by Region, 2019
  • Figure 07: Global Epileptic Seizures Treatment Market Value Share, by Status Epilepticus, 2019
  • Figure 08: Global Epileptic Seizures Treatment Market Value Share Analysis, by Therapeutics, 2019 and 2030
  • Figure 09: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Midazolam, 2018-2030
  • Figure 10: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Alprazolam, 2018-2030
  • Figure 11: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Diazepam, 2018-2030
  • Figure 12: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Lorazepam, 2018-2030
  • Figure 13: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Phenytoin, 2018-2030
  • Figure 14: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Fosphenytoin, 2018-2030
  • Figure 15: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Others, 2018-2030
  • Figure 16: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020-2030
  • Figure 17: Global Epileptic Seizures Treatment Market Value Share Analysis, by Type, 2019 and 2030
  • Figure 18: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Repetitive Seizures, 2018-2030
  • Figure 19: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Status Epilepticus, 2018-2030
  • Figure 20: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Others, 2018-2030
  • Figure 21: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020-2030
  • Figure 22: Global Epileptic Seizures Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 23: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Oral/Buccal, 2018-2030
  • Figure 24: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Rectal, 2018-2030
  • Figure 25: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Nasal, 2018-2030
  • Figure 26: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Parenteral, 2018-2030
  • Figure 27: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 28: Global Epileptic Seizures Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 29: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2030
  • Figure 30: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018-2030
  • Figure 31: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Online Pharmacies, 2018-2030
  • Figure 32: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 33: Global Epileptic Seizures Treatment Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 34: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Region, 2020-2030
  • Figure 35: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 36: North America Epileptic Seizures Treatment Market Value Share (%), by Country, 2019 and 2030
  • Figure 37: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 38: North America Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030
  • Figure 39: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020-2030
  • Figure 40: North America Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030
  • Figure 41: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020-2030
  • Figure 42: North America Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
  • Figure 43: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 44: North America Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 45: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 46: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 47: Europe Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
  • Figure 48: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 49: Europe Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030
  • Figure 50: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020-2030
  • Figure 51: Europe Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030
  • Figure 52: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020-2030
  • Figure 53: Europe Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
  • Figure 54: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 55: Europe Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 56: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 57: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 58: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
  • Figure 59: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 60: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030
  • Figure 61: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020-2030
  • Figure 62: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030
  • Figure 63: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020-2030
  • Figure 64: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
  • Figure 65: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 66: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 67: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 68: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 69: Latin America Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
  • Figure 70: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 71: Latin America Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030
  • Figure 72: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020-2030
  • Figure 73: Latin America Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030
  • Figure 74: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020-2030
  • Figure 75: Latin America Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
  • Figure 76: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 77: Latin America Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 78: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 79: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 80: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030
  • Figure 81: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 82: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030
  • Figure 83: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020-2030
  • Figure 84: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030
  • Figure 85: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020-2030
  • Figure 86: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030
  • Figure 87: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 88: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 89: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 90: Market Position/Ranking Analysis, 2019, by Tier and Size of the Company